Detalhe da pesquisa
1.
Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer's disease.
Acta Neuropathol Commun
; 8(1): 13, 2020 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32019610
2.
Preclinical in vivo characterization of lemborexant (E2006), a novel dual orexin receptor antagonist for sleep/wake regulation.
Sleep
; 42(6)2019 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30923834
3.
Donepezil attenuates excitotoxic damage induced by membrane depolarization of cortical neurons exposed to veratridine.
Eur J Pharmacol
; 588(2-3): 189-97, 2008 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-18508044
4.
Protective effect of donepezil in primary-cultured rat cortical neurons exposed to N-methyl-d-aspartate (NMDA) toxicity.
Eur J Pharmacol
; 530(3): 215-22, 2006 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-16406045
5.
Protective effect of donepezil against Abeta(1-40) neurotoxicity in rat septal neurons.
Brain Res
; 1047(1): 72-84, 2005 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-15893738
6.
PE859, a novel tau aggregation inhibitor, reduces aggregated tau and prevents onset and progression of neural dysfunction in vivo.
PLoS One
; 10(2): e0117511, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25659102
7.
Protective effect of donepezil in a primary culture of rat cortical neurons exposed to oxygen-glucose deprivation.
Eur J Pharmacol
; 472(1-2): 57-63, 2003 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-12860473